GI Cancer

April 5, 2021

Circulating hybrid cells are evaluated as a biomarker of treatment response in patients with rectal and esophageal cancers

The team previously demonstrated that circulating hybrid cells (CD45-positive/CK-positive) are found in high numbers in pancreatic adenocarcinoma and are better correlated with overall survival than traditional circulating tumor […]
August 10, 2020

Study evaluates degree of response associated with chemotherapy with FOLFIRINOX or Gemcitabine plus Nab-Paclitaxel in the first line in the treatment of resectable pancreatic adenocarcinoma

FOLFIRINOX and Gemcitabine plus Nab-Paclitaxel are first-line chemotherapy regimens for pancreatic cancer, but their relative efficacy in localized disease is unknown. Recently, a study published in […]
July 13, 2020

CAPP2 study evaluates aspirin use in primary prophylaxis for colorectal cancer related to Lynch syndrome

The results are from a 10-year follow-up and were published in The Lancet magazine Lynch syndrome is associated with an increased risk of colorectal cancer. Randomized […]